

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 7.56284488 |
| 2 | DNA deamination (GO:0045006) | 7.01560683 |
| 3 | cytidine metabolic process (GO:0046087) | 6.99808783 |
| 4 | cytidine catabolic process (GO:0006216) | 6.99808783 |
| 5 | cytidine deamination (GO:0009972) | 6.99808783 |
| 6 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 6.95393007 |
| 7 | actin nucleation (GO:0045010) | 6.25476525 |
| 8 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 6.12210471 |
| 9 | negative T cell selection (GO:0043383) | 5.05587450 |
| 10 | sequestering of actin monomers (GO:0042989) | 4.96538897 |
| 11 | cellular response to interleukin-15 (GO:0071350) | 4.56610522 |
| 12 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 4.43601800 |
| 13 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 4.29825121 |
| 14 | negative thymic T cell selection (GO:0045060) | 4.24709537 |
| 15 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.17259984 |
| 16 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 4.06302170 |
| 17 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.93055018 |
| 18 | negative regulation of T cell apoptotic process (GO:0070233) | 3.87667249 |
| 19 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.83454209 |
| 20 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.83454209 |
| 21 | positive T cell selection (GO:0043368) | 3.82708902 |
| 22 | positive thymic T cell selection (GO:0045059) | 3.74276508 |
| 23 | adaptation of signaling pathway (GO:0023058) | 3.73874545 |
| 24 | positive regulation of defense response to virus by host (GO:0002230) | 3.71404135 |
| 25 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.66344007 |
| 26 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.63448225 |
| 27 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 3.61989472 |
| 28 | negative regulation of stress fiber assembly (GO:0051497) | 3.61187806 |
| 29 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.58606758 |
| 30 | positive regulation of cell killing (GO:0031343) | 3.53485769 |
| 31 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.50604455 |
| 32 | negative regulation by host of viral transcription (GO:0043922) | 3.49628774 |
| 33 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.47810529 |
| 34 | thymic T cell selection (GO:0045061) | 3.47368064 |
| 35 | purine deoxyribonucleotide catabolic process (GO:0009155) | 3.46222559 |
| 36 | T cell migration (GO:0072678) | 3.44541283 |
| 37 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.38964156 |
| 38 | platelet dense granule organization (GO:0060155) | 3.37427256 |
| 39 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.33627398 |
| 40 | response to interleukin-15 (GO:0070672) | 3.32377258 |
| 41 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.30459521 |
| 42 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.29997902 |
| 43 | ATP synthesis coupled proton transport (GO:0015986) | 3.29997902 |
| 44 | positive regulation of interleukin-8 secretion (GO:2000484) | 3.29517049 |
| 45 | iron-sulfur cluster assembly (GO:0016226) | 3.24973065 |
| 46 | metallo-sulfur cluster assembly (GO:0031163) | 3.24973065 |
| 47 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.24596534 |
| 48 | positive regulation of calcium-mediated signaling (GO:0050850) | 3.24410176 |
| 49 | regulation of cell killing (GO:0031341) | 3.19167922 |
| 50 | regulation of T cell receptor signaling pathway (GO:0050856) | 3.18036895 |
| 51 | regulation of activation of Janus kinase activity (GO:0010533) | 3.17751735 |
| 52 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.14601351 |
| 53 | regulation of regulatory T cell differentiation (GO:0045589) | 3.13872285 |
| 54 | pyrimidine nucleoside catabolic process (GO:0046135) | 3.12433745 |
| 55 | cytolysis (GO:0019835) | 3.05949063 |
| 56 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.05651366 |
| 57 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.03432016 |
| 58 | T cell receptor signaling pathway (GO:0050852) | 3.03403739 |
| 59 | negative regulation of lymphocyte apoptotic process (GO:0070229) | 3.00320706 |
| 60 | purine deoxyribonucleotide metabolic process (GO:0009151) | 2.98770610 |
| 61 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.98169304 |
| 62 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 2.97404048 |
| 63 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 2.97404048 |
| 64 | protein neddylation (GO:0045116) | 2.97365956 |
| 65 | response to interferon-beta (GO:0035456) | 2.97197564 |
| 66 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.94061840 |
| 67 | negative regulation of actin filament bundle assembly (GO:0032232) | 2.94029924 |
| 68 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.92279567 |
| 69 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.92279567 |
| 70 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.91204396 |
| 71 | regulation of isotype switching to IgG isotypes (GO:0048302) | 2.90969694 |
| 72 | T cell costimulation (GO:0031295) | 2.90849453 |
| 73 | T cell selection (GO:0045058) | 2.90786078 |
| 74 | negative regulation of viral genome replication (GO:0045071) | 2.90741115 |
| 75 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.90653615 |
| 76 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.90653615 |
| 77 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.90653615 |
| 78 | cellular defense response (GO:0006968) | 2.89428118 |
| 79 | lymphocyte costimulation (GO:0031294) | 2.87319892 |
| 80 | positive regulation of uterine smooth muscle contraction (GO:0070474) | 2.86870725 |
| 81 | respiratory electron transport chain (GO:0022904) | 2.86543449 |
| 82 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.86174571 |
| 83 | positive regulation of prostaglandin secretion (GO:0032308) | 2.85440005 |
| 84 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.85419785 |
| 85 | negative regulation of nitric-oxide synthase activity (GO:0051001) | 2.84370058 |
| 86 | electron transport chain (GO:0022900) | 2.84236285 |
| 87 | protein deneddylation (GO:0000338) | 2.83912396 |
| 88 | negative regulation of mast cell activation (GO:0033004) | 2.82884088 |
| 89 | regulation of interleukin-8 secretion (GO:2000482) | 2.82158803 |
| 90 | regulation of defense response to virus by host (GO:0050691) | 2.80809486 |
| 91 | protein complex biogenesis (GO:0070271) | 2.78417231 |
| 92 | base-excision repair, AP site formation (GO:0006285) | 2.77702543 |
| 93 | deoxyribonucleoside triphosphate metabolic process (GO:0009200) | 2.74375416 |
| 94 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.74318967 |
| 95 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.74318967 |
| 96 | negative regulation of oxidoreductase activity (GO:0051354) | 2.74007142 |
| 97 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.72898918 |
| 98 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.72158762 |
| 99 | mast cell activation (GO:0045576) | 2.71154158 |
| 100 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.69764624 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.61075213 |
| 2 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 4.28718492 |
| 3 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.65376354 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.45853468 |
| 5 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.38306671 |
| 6 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 3.11494825 |
| 7 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.08394357 |
| 8 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.91051524 |
| 9 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.83751466 |
| 10 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.62659755 |
| 11 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.52235560 |
| 12 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.43917064 |
| 13 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.41505950 |
| 14 | MYB_26560356_Chip-Seq_TH2_Human | 2.32634874 |
| 15 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.31329627 |
| 16 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.26325825 |
| 17 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.19198998 |
| 18 | VDR_22108803_ChIP-Seq_LS180_Human | 2.18956645 |
| 19 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.08237561 |
| 20 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.06464157 |
| 21 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.05697990 |
| 22 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.96255170 |
| 23 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.95646561 |
| 24 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.94247595 |
| 25 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.92562882 |
| 26 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.90947605 |
| 27 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.87245333 |
| 28 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.82200879 |
| 29 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.81028489 |
| 30 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.75861639 |
| 31 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.73236471 |
| 32 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.69764046 |
| 33 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.69381881 |
| 34 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 1.67086939 |
| 35 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.63057591 |
| 36 | GATA3_26560356_Chip-Seq_TH2_Human | 1.59098960 |
| 37 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.55004412 |
| 38 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.50295444 |
| 39 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.48512328 |
| 40 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.45656666 |
| 41 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.41773144 |
| 42 | UTX_26944678_Chip-Seq_JUKART_Human | 1.35888242 |
| 43 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.33435128 |
| 44 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.33244637 |
| 45 | AR_20517297_ChIP-Seq_VCAP_Human | 1.33239901 |
| 46 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.32298065 |
| 47 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.31449945 |
| 48 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.30297245 |
| 49 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.29930684 |
| 50 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.29609901 |
| 51 | MYB_26560356_Chip-Seq_TH1_Human | 1.28041603 |
| 52 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.26547868 |
| 53 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.25965150 |
| 54 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.25681166 |
| 55 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.25448758 |
| 56 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.24181402 |
| 57 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.23609290 |
| 58 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.22374799 |
| 59 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.21401269 |
| 60 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.20266258 |
| 61 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.18493854 |
| 62 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.17484030 |
| 63 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.13764691 |
| 64 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.12309999 |
| 65 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.11606145 |
| 66 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.10954328 |
| 67 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.10912858 |
| 68 | NCOR_22424771_ChIP-Seq_293T_Human | 1.10849312 |
| 69 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.10840803 |
| 70 | TAF2_19829295_ChIP-Seq_ESCs_Human | 1.10695458 |
| 71 | ERG_20517297_ChIP-Seq_VCAP_Human | 1.10318385 |
| 72 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.09610267 |
| 73 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.09315374 |
| 74 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.05352199 |
| 75 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.05352199 |
| 76 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.05005322 |
| 77 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.04510176 |
| 78 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.04403546 |
| 79 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 1.04085528 |
| 80 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 1.03071246 |
| 81 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.01767761 |
| 82 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.00551687 |
| 83 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.00335041 |
| 84 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.99496442 |
| 85 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.99233347 |
| 86 | EWS_26573619_Chip-Seq_HEK293_Human | 0.99036819 |
| 87 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.98616755 |
| 88 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.98616755 |
| 89 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.95420216 |
| 90 | P300_27268052_Chip-Seq_Bcells_Human | 0.94865212 |
| 91 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 0.94739429 |
| 92 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.94405707 |
| 93 | MAF_26560356_Chip-Seq_TH1_Human | 0.93982064 |
| 94 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.93881823 |
| 95 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.93176106 |
| 96 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.92896252 |
| 97 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.91535630 |
| 98 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.90282908 |
| 99 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.90282908 |
| 100 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.90266873 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005671_abnormal_response_to | 5.66585584 |
| 2 | MP0009785_altered_susceptibility_to | 3.33017494 |
| 3 | MP0003763_abnormal_thymus_physiology | 3.03510668 |
| 4 | MP0001835_abnormal_antigen_presentation | 2.76698582 |
| 5 | MP0002166_altered_tumor_susceptibility | 2.38238737 |
| 6 | MP0001800_abnormal_humoral_immune | 2.36311761 |
| 7 | MP0005000_abnormal_immune_tolerance | 2.32707138 |
| 8 | MP0002148_abnormal_hypersensitivity_rea | 2.23137255 |
| 9 | MP0004147_increased_porphyrin_level | 2.22495008 |
| 10 | MP0003786_premature_aging | 2.20377544 |
| 11 | MP0002420_abnormal_adaptive_immunity | 2.18093506 |
| 12 | MP0005025_abnormal_response_to | 2.18059983 |
| 13 | MP0001819_abnormal_immune_cell | 2.12762849 |
| 14 | MP0003866_abnormal_defecation | 2.10291598 |
| 15 | MP0002723_abnormal_immune_serum | 2.06324465 |
| 16 | MP0002102_abnormal_ear_morphology | 2.02888917 |
| 17 | MP0006072_abnormal_retinal_apoptosis | 1.96001611 |
| 18 | MP0002736_abnormal_nociception_after | 1.87936939 |
| 19 | MP0009333_abnormal_splenocyte_physiolog | 1.86365226 |
| 20 | MP0002452_abnormal_antigen_presenting | 1.85647113 |
| 21 | MP0002006_tumorigenesis | 1.82088406 |
| 22 | MP0000685_abnormal_immune_system | 1.81924697 |
| 23 | MP0008875_abnormal_xenobiotic_pharmacok | 1.77280792 |
| 24 | MP0001790_abnormal_immune_system | 1.70801654 |
| 25 | MP0005387_immune_system_phenotype | 1.70801654 |
| 26 | MP0002398_abnormal_bone_marrow | 1.68871341 |
| 27 | MP0003646_muscle_fatigue | 1.68491408 |
| 28 | MP0000716_abnormal_immune_system | 1.64708677 |
| 29 | MP0008872_abnormal_physiological_respon | 1.63863864 |
| 30 | MP0004145_abnormal_muscle_electrophysio | 1.63473016 |
| 31 | MP0005645_abnormal_hypothalamus_physiol | 1.61162550 |
| 32 | MP0002933_joint_inflammation | 1.58355213 |
| 33 | MP0001968_abnormal_touch/_nociception | 1.57879789 |
| 34 | MP0002277_abnormal_respiratory_mucosa | 1.54766172 |
| 35 | MP0006082_CNS_inflammation | 1.53980414 |
| 36 | MP0000689_abnormal_spleen_morphology | 1.49174028 |
| 37 | MP0005084_abnormal_gallbladder_morpholo | 1.48607129 |
| 38 | MP0005646_abnormal_pituitary_gland | 1.45892269 |
| 39 | MP0005551_abnormal_eye_electrophysiolog | 1.43337252 |
| 40 | MP0002405_respiratory_system_inflammati | 1.40503261 |
| 41 | MP0001905_abnormal_dopamine_level | 1.38590953 |
| 42 | MP0010155_abnormal_intestine_physiology | 1.37364235 |
| 43 | MP0001845_abnormal_inflammatory_respons | 1.36679190 |
| 44 | MP0005253_abnormal_eye_physiology | 1.35065332 |
| 45 | MP0002722_abnormal_immune_system | 1.34633295 |
| 46 | MP0006054_spinal_hemorrhage | 1.33936652 |
| 47 | MP0002429_abnormal_blood_cell | 1.32331810 |
| 48 | MP0001764_abnormal_homeostasis | 1.32048976 |
| 49 | MP0000703_abnormal_thymus_morphology | 1.28472226 |
| 50 | MP0008789_abnormal_olfactory_epithelium | 1.26797063 |
| 51 | MP0003724_increased_susceptibility_to | 1.25707548 |
| 52 | MP0003252_abnormal_bile_duct | 1.24632034 |
| 53 | MP0008877_abnormal_DNA_methylation | 1.21971585 |
| 54 | MP0002876_abnormal_thyroid_physiology | 1.21076266 |
| 55 | MP0001873_stomach_inflammation | 1.18557112 |
| 56 | MP0002419_abnormal_innate_immunity | 1.18395491 |
| 57 | MP0005075_abnormal_melanosome_morpholog | 1.16055113 |
| 58 | MP0002234_abnormal_pharynx_morphology | 1.15333475 |
| 59 | MP0005410_abnormal_fertilization | 1.15020953 |
| 60 | MP0000372_irregular_coat_pigmentation | 1.14972185 |
| 61 | MP0008469_abnormal_protein_level | 1.12122542 |
| 62 | MP0010386_abnormal_urinary_bladder | 1.09716303 |
| 63 | MP0005083_abnormal_biliary_tract | 1.09660264 |
| 64 | MP0001853_heart_inflammation | 1.06309002 |
| 65 | MP0009764_decreased_sensitivity_to | 1.05150546 |
| 66 | MP0002138_abnormal_hepatobiliary_system | 1.03502798 |
| 67 | MP0006036_abnormal_mitochondrial_physio | 0.98718043 |
| 68 | MP0001986_abnormal_taste_sensitivity | 0.97390352 |
| 69 | MP0003045_fibrosis | 0.95442558 |
| 70 | MP0008058_abnormal_DNA_repair | 0.93158814 |
| 71 | MP0002693_abnormal_pancreas_physiology | 0.93095583 |
| 72 | MP0008995_early_reproductive_senescence | 0.92719128 |
| 73 | MP0003436_decreased_susceptibility_to | 0.91795452 |
| 74 | MP0003448_altered_tumor_morphology | 0.91215919 |
| 75 | MP0003806_abnormal_nucleotide_metabolis | 0.90856355 |
| 76 | MP0003011_delayed_dark_adaptation | 0.90747659 |
| 77 | MP0001661_extended_life_span | 0.88181650 |
| 78 | MP0001501_abnormal_sleep_pattern | 0.88053210 |
| 79 | MP0002019_abnormal_tumor_incidence | 0.85423766 |
| 80 | MP0002837_dystrophic_cardiac_calcinosis | 0.85120968 |
| 81 | MP0001765_abnormal_ion_homeostasis | 0.84101810 |
| 82 | MP0002095_abnormal_skin_pigmentation | 0.83297446 |
| 83 | MP0003283_abnormal_digestive_organ | 0.81316144 |
| 84 | MP0009763_increased_sensitivity_to | 0.80843178 |
| 85 | MP0003195_calcinosis | 0.80593086 |
| 86 | MP0006276_abnormal_autonomic_nervous | 0.77102598 |
| 87 | MP0003880_abnormal_central_pattern | 0.76825739 |
| 88 | MP0005636_abnormal_mineral_homeostasis | 0.76774077 |
| 89 | MP0005464_abnormal_platelet_physiology | 0.76539940 |
| 90 | MP0005377_hearing/vestibular/ear_phenot | 0.75480894 |
| 91 | MP0003878_abnormal_ear_physiology | 0.75480894 |
| 92 | MP0004885_abnormal_endolymph | 0.74811398 |
| 93 | MP0009765_abnormal_xenobiotic_induced | 0.71663109 |
| 94 | MP0004134_abnormal_chest_morphology | 0.71489079 |
| 95 | MP0009643_abnormal_urine_homeostasis | 0.67393577 |
| 96 | MP0001542_abnormal_bone_strength | 0.65688126 |
| 97 | MP0009697_abnormal_copulation | 0.65657849 |
| 98 | MP0010094_abnormal_chromosome_stability | 0.65255747 |
| 99 | MP0003137_abnormal_impulse_conducting | 0.64815870 |
| 100 | MP0001119_abnormal_female_reproductive | 0.64325638 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IgG deficiency (HP:0004315) | 4.97453536 |
| 2 | Severe combined immunodeficiency (HP:0004430) | 4.67540084 |
| 3 | T lymphocytopenia (HP:0005403) | 4.58676769 |
| 4 | Abnormality of T cell number (HP:0011839) | 4.47745572 |
| 5 | Aplastic anemia (HP:0001915) | 4.45428366 |
| 6 | Increased IgM level (HP:0003496) | 3.83870710 |
| 7 | Hypoproteinemia (HP:0003075) | 3.82752369 |
| 8 | Autoimmune hemolytic anemia (HP:0001890) | 3.79782764 |
| 9 | Mitochondrial inheritance (HP:0001427) | 3.79439004 |
| 10 | Combined immunodeficiency (HP:0005387) | 3.72466556 |
| 11 | Acute necrotizing encephalopathy (HP:0006965) | 3.47315223 |
| 12 | Abnormality of T cells (HP:0002843) | 3.44621664 |
| 13 | Hepatocellular necrosis (HP:0001404) | 3.37788694 |
| 14 | Abolished electroretinogram (ERG) (HP:0000550) | 3.37482031 |
| 15 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.35579065 |
| 16 | Abnormality of B cell number (HP:0010975) | 3.35232199 |
| 17 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 3.29832627 |
| 18 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.22353601 |
| 19 | Congenital stationary night blindness (HP:0007642) | 3.21646825 |
| 20 | Chronic diarrhea (HP:0002028) | 3.18301534 |
| 21 | Increased CSF lactate (HP:0002490) | 3.13323798 |
| 22 | Thyroiditis (HP:0100646) | 3.06429081 |
| 23 | Hepatic necrosis (HP:0002605) | 2.97054987 |
| 24 | B lymphocytopenia (HP:0010976) | 2.93316842 |
| 25 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.88905549 |
| 26 | Pancytopenia (HP:0001876) | 2.86229944 |
| 27 | Abnormality of eosinophils (HP:0001879) | 2.82830349 |
| 28 | Agammaglobulinemia (HP:0004432) | 2.77836753 |
| 29 | Acute encephalopathy (HP:0006846) | 2.75744052 |
| 30 | Renal Fanconi syndrome (HP:0001994) | 2.75701255 |
| 31 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.75257935 |
| 32 | Progressive macrocephaly (HP:0004481) | 2.74283469 |
| 33 | IgM deficiency (HP:0002850) | 2.69685240 |
| 34 | Stomatitis (HP:0010280) | 2.66941739 |
| 35 | Increased intramyocellular lipid droplets (HP:0012240) | 2.66893301 |
| 36 | Abnormality of the prostate (HP:0008775) | 2.66196415 |
| 37 | Autoimmune thrombocytopenia (HP:0001973) | 2.65854003 |
| 38 | Decreased central vision (HP:0007663) | 2.64773075 |
| 39 | Renal cortical cysts (HP:0000803) | 2.57242586 |
| 40 | Pancreatic cysts (HP:0001737) | 2.54606038 |
| 41 | Increased hepatocellular lipid droplets (HP:0006565) | 2.54483747 |
| 42 | Recurrent bronchitis (HP:0002837) | 2.46806632 |
| 43 | Attenuation of retinal blood vessels (HP:0007843) | 2.45426137 |
| 44 | Oral leukoplakia (HP:0002745) | 2.38061312 |
| 45 | 3-Methylglutaconic aciduria (HP:0003535) | 2.36716117 |
| 46 | Cerebral edema (HP:0002181) | 2.36178143 |
| 47 | Cerebral palsy (HP:0100021) | 2.36125304 |
| 48 | Optic disc pallor (HP:0000543) | 2.29739548 |
| 49 | Lipid accumulation in hepatocytes (HP:0006561) | 2.29664137 |
| 50 | Respiratory failure (HP:0002878) | 2.28309801 |
| 51 | Type I transferrin isoform profile (HP:0003642) | 2.27490221 |
| 52 | Type 2 muscle fiber atrophy (HP:0003554) | 2.26379251 |
| 53 | Increased muscle lipid content (HP:0009058) | 2.25890374 |
| 54 | Abnormality of T cell physiology (HP:0011840) | 2.25831289 |
| 55 | Methylmalonic aciduria (HP:0012120) | 2.25300190 |
| 56 | Increased serum lactate (HP:0002151) | 2.24122483 |
| 57 | Lymphopenia (HP:0001888) | 2.21553045 |
| 58 | Encephalitis (HP:0002383) | 2.21504800 |
| 59 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.21362714 |
| 60 | Methylmalonic acidemia (HP:0002912) | 2.19588136 |
| 61 | Abnormal albumin level (HP:0012116) | 2.17030349 |
| 62 | Hypoalbuminemia (HP:0003073) | 2.17030349 |
| 63 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.16627625 |
| 64 | Recurrent cutaneous fungal infections (HP:0011370) | 2.16627625 |
| 65 | Generalized aminoaciduria (HP:0002909) | 2.16548216 |
| 66 | Abnormality of the renal cortex (HP:0011035) | 2.14214599 |
| 67 | Eosinophilia (HP:0001880) | 2.12324182 |
| 68 | Lactic acidosis (HP:0003128) | 2.09066296 |
| 69 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.09050781 |
| 70 | Dicarboxylic aciduria (HP:0003215) | 2.08516681 |
| 71 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.08516681 |
| 72 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.08265715 |
| 73 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.08265715 |
| 74 | Abnormality of the renal collecting system (HP:0004742) | 2.04786095 |
| 75 | Pancreatic fibrosis (HP:0100732) | 2.04106008 |
| 76 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.03833174 |
| 77 | Abnormality of midbrain morphology (HP:0002418) | 2.03599992 |
| 78 | Molar tooth sign on MRI (HP:0002419) | 2.03599992 |
| 79 | Bronchitis (HP:0012387) | 1.97909137 |
| 80 | Joint swelling (HP:0001386) | 1.97520328 |
| 81 | Granulocytopenia (HP:0001913) | 1.96886969 |
| 82 | Pendular nystagmus (HP:0012043) | 1.95644083 |
| 83 | True hermaphroditism (HP:0010459) | 1.95579681 |
| 84 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.95451757 |
| 85 | Mesangial abnormality (HP:0001966) | 1.94828674 |
| 86 | Keratoconus (HP:0000563) | 1.94605444 |
| 87 | Increased corneal curvature (HP:0100692) | 1.94605444 |
| 88 | Severe visual impairment (HP:0001141) | 1.91359913 |
| 89 | Recurrent fungal infections (HP:0002841) | 1.90067825 |
| 90 | Neonatal respiratory distress (HP:0002643) | 1.89623558 |
| 91 | Meningitis (HP:0001287) | 1.88815025 |
| 92 | Hypoplasia of the thymus (HP:0000778) | 1.82478673 |
| 93 | Constricted visual fields (HP:0001133) | 1.82415249 |
| 94 | Exercise intolerance (HP:0003546) | 1.81716107 |
| 95 | Muscle fiber atrophy (HP:0100295) | 1.81432339 |
| 96 | Hypergammaglobulinemia (HP:0010702) | 1.80186816 |
| 97 | Short tibia (HP:0005736) | 1.79480193 |
| 98 | Leukocytosis (HP:0001974) | 1.78541599 |
| 99 | Colon cancer (HP:0003003) | 1.77505926 |
| 100 | Lethargy (HP:0001254) | 1.76369665 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TXK | 6.28476760 |
| 2 | KDR | 5.74137375 |
| 3 | TESK2 | 5.17984317 |
| 4 | BCKDK | 3.08126079 |
| 5 | TAOK3 | 2.89069795 |
| 6 | VRK2 | 2.36199271 |
| 7 | MAP4K1 | 2.31148323 |
| 8 | TIE1 | 2.30699009 |
| 9 | ITK | 2.24374656 |
| 10 | LIMK1 | 2.21213537 |
| 11 | TESK1 | 2.18452308 |
| 12 | SCYL2 | 2.13120639 |
| 13 | MAP4K2 | 2.12119866 |
| 14 | STK16 | 1.86847623 |
| 15 | ZAK | 1.79843652 |
| 16 | TLK1 | 1.61874048 |
| 17 | GRK7 | 1.59240478 |
| 18 | VRK1 | 1.57170944 |
| 19 | MAP3K12 | 1.53101664 |
| 20 | TEC | 1.51820622 |
| 21 | ADRBK2 | 1.50323750 |
| 22 | NUAK1 | 1.48264974 |
| 23 | GRK1 | 1.29956721 |
| 24 | IKBKE | 1.27770091 |
| 25 | NME1 | 1.22190105 |
| 26 | FES | 1.21743173 |
| 27 | MAPKAPK3 | 1.20402461 |
| 28 | SYK | 1.19729266 |
| 29 | MUSK | 1.18520774 |
| 30 | BCR | 1.15880541 |
| 31 | BUB1 | 1.15685995 |
| 32 | DAPK1 | 1.13043342 |
| 33 | GRK6 | 1.09227251 |
| 34 | TBK1 | 1.01749933 |
| 35 | MAP3K11 | 0.95064364 |
| 36 | TNK2 | 0.94161477 |
| 37 | PRKCQ | 0.93414711 |
| 38 | CSNK1G3 | 0.92042737 |
| 39 | LCK | 0.89008742 |
| 40 | KIT | 0.84336314 |
| 41 | CSF1R | 0.84103220 |
| 42 | BTK | 0.83390091 |
| 43 | MAPK13 | 0.79154583 |
| 44 | IKBKB | 0.77628892 |
| 45 | LYN | 0.76325337 |
| 46 | INSRR | 0.74780783 |
| 47 | GRK5 | 0.71930759 |
| 48 | CSNK1A1L | 0.71409882 |
| 49 | WNK4 | 0.65310737 |
| 50 | ERBB3 | 0.64695147 |
| 51 | MAP2K7 | 0.62476321 |
| 52 | CDK19 | 0.61624588 |
| 53 | RPS6KA5 | 0.59862159 |
| 54 | TRIM28 | 0.59696475 |
| 55 | STK10 | 0.59066379 |
| 56 | MYLK | 0.57631585 |
| 57 | RPS6KA4 | 0.57086567 |
| 58 | ZAP70 | 0.56788893 |
| 59 | OBSCN | 0.56537620 |
| 60 | PASK | 0.55092852 |
| 61 | OXSR1 | 0.54484018 |
| 62 | CSK | 0.54321645 |
| 63 | CSNK1G2 | 0.54061411 |
| 64 | WNK3 | 0.52660332 |
| 65 | CSNK1G1 | 0.52619901 |
| 66 | IGF1R | 0.52311997 |
| 67 | EPHA4 | 0.51787049 |
| 68 | MST4 | 0.44898951 |
| 69 | MAP3K5 | 0.40878737 |
| 70 | EIF2AK3 | 0.40220171 |
| 71 | PIM1 | 0.38295500 |
| 72 | JAK3 | 0.38028877 |
| 73 | AURKA | 0.37962513 |
| 74 | PINK1 | 0.37386761 |
| 75 | BMPR2 | 0.37091456 |
| 76 | FYN | 0.36718475 |
| 77 | PIK3CA | 0.36458920 |
| 78 | PHKG2 | 0.35701220 |
| 79 | PHKG1 | 0.35701220 |
| 80 | TGFBR2 | 0.34942468 |
| 81 | ADRBK1 | 0.34805328 |
| 82 | STK39 | 0.33481256 |
| 83 | PRKCA | 0.31497770 |
| 84 | MAP2K6 | 0.30791153 |
| 85 | MAP3K4 | 0.30209393 |
| 86 | ROCK1 | 0.29755814 |
| 87 | DAPK2 | 0.29734953 |
| 88 | MAPKAPK5 | 0.29328404 |
| 89 | ATR | 0.28016670 |
| 90 | FRK | 0.27991216 |
| 91 | CSNK1A1 | 0.26763994 |
| 92 | PAK1 | 0.26759977 |
| 93 | MAPKAPK2 | 0.26327983 |
| 94 | PLK4 | 0.26276009 |
| 95 | PRKCD | 0.26104918 |
| 96 | CSNK2A1 | 0.25811998 |
| 97 | PRKCH | 0.25183421 |
| 98 | BMPR1B | 0.22995453 |
| 99 | ABL1 | 0.22822422 |
| 100 | CAMK2A | 0.22401561 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 5.12769074 |
| 2 | Proteasome_Homo sapiens_hsa03050 | 4.41634552 |
| 3 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.27052784 |
| 4 | Antigen processing and presentation_Homo sapiens_hsa04612 | 3.03725109 |
| 5 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.78534288 |
| 6 | Parkinsons disease_Homo sapiens_hsa05012 | 2.56454199 |
| 7 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.51296988 |
| 8 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.42017566 |
| 9 | Allograft rejection_Homo sapiens_hsa05330 | 2.37944242 |
| 10 | Protein export_Homo sapiens_hsa03060 | 2.15764673 |
| 11 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.14923734 |
| 12 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.02239110 |
| 13 | Phototransduction_Homo sapiens_hsa04744 | 2.00963796 |
| 14 | RNA polymerase_Homo sapiens_hsa03020 | 1.94515144 |
| 15 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.85532234 |
| 16 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.81992907 |
| 17 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.80559802 |
| 18 | Alzheimers disease_Homo sapiens_hsa05010 | 1.70122502 |
| 19 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.69052584 |
| 20 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.67460461 |
| 21 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.60758349 |
| 22 | Huntingtons disease_Homo sapiens_hsa05016 | 1.47473833 |
| 23 | Ribosome_Homo sapiens_hsa03010 | 1.30808115 |
| 24 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.24756211 |
| 25 | Asthma_Homo sapiens_hsa05310 | 1.23930258 |
| 26 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.23505722 |
| 27 | DNA replication_Homo sapiens_hsa03030 | 1.23078142 |
| 28 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.21554657 |
| 29 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.20978521 |
| 30 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.18504308 |
| 31 | Shigellosis_Homo sapiens_hsa05131 | 1.15635467 |
| 32 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.15137558 |
| 33 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.13892324 |
| 34 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.12222624 |
| 35 | Homologous recombination_Homo sapiens_hsa03440 | 1.08752204 |
| 36 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.08621167 |
| 37 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.07927337 |
| 38 | Viral myocarditis_Homo sapiens_hsa05416 | 1.06679132 |
| 39 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.00559110 |
| 40 | Measles_Homo sapiens_hsa05162 | 0.99565573 |
| 41 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.99227166 |
| 42 | Base excision repair_Homo sapiens_hsa03410 | 0.98618258 |
| 43 | Purine metabolism_Homo sapiens_hsa00230 | 0.96754947 |
| 44 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.96607798 |
| 45 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.93836084 |
| 46 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.91852049 |
| 47 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.91001210 |
| 48 | RNA degradation_Homo sapiens_hsa03018 | 0.86545071 |
| 49 | Salmonella infection_Homo sapiens_hsa05132 | 0.82444817 |
| 50 | Peroxisome_Homo sapiens_hsa04146 | 0.81769176 |
| 51 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.81433353 |
| 52 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.79716552 |
| 53 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.77645769 |
| 54 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.72098250 |
| 55 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.71498868 |
| 56 | Malaria_Homo sapiens_hsa05144 | 0.70492818 |
| 57 | Mismatch repair_Homo sapiens_hsa03430 | 0.68940930 |
| 58 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.67295669 |
| 59 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.66397502 |
| 60 | Taste transduction_Homo sapiens_hsa04742 | 0.62835208 |
| 61 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.60639235 |
| 62 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.59609738 |
| 63 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.59551841 |
| 64 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.59415826 |
| 65 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.57012678 |
| 66 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.56455724 |
| 67 | Olfactory transduction_Homo sapiens_hsa04740 | 0.55017952 |
| 68 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.50771957 |
| 69 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.48426105 |
| 70 | Retinol metabolism_Homo sapiens_hsa00830 | 0.46798919 |
| 71 | Spliceosome_Homo sapiens_hsa03040 | 0.46740991 |
| 72 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.46597422 |
| 73 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.45333917 |
| 74 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.44523410 |
| 75 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.44381509 |
| 76 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.43177640 |
| 77 | Metabolic pathways_Homo sapiens_hsa01100 | 0.43133934 |
| 78 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.40857158 |
| 79 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.39518896 |
| 80 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.38042650 |
| 81 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.33699556 |
| 82 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.33299687 |
| 83 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.32907517 |
| 84 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.32084552 |
| 85 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.30116841 |
| 86 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.29673941 |
| 87 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.29127298 |
| 88 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.28519952 |
| 89 | Salivary secretion_Homo sapiens_hsa04970 | 0.28399221 |
| 90 | Nicotine addiction_Homo sapiens_hsa05033 | 0.27954616 |
| 91 | Morphine addiction_Homo sapiens_hsa05032 | 0.27334440 |
| 92 | Sulfur relay system_Homo sapiens_hsa04122 | 0.26406896 |
| 93 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.26315131 |
| 94 | RNA transport_Homo sapiens_hsa03013 | 0.25634577 |
| 95 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.23511038 |
| 96 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.23191573 |
| 97 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.22256719 |
| 98 | Legionellosis_Homo sapiens_hsa05134 | 0.21123742 |
| 99 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.20299767 |
| 100 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.19785484 |

